TherapeuticsMD
TXMD
TXMD
42 hedge funds and large institutions have $12.5M invested in TherapeuticsMD in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
+1
Holders Change %
+2.44%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
7
Closed
3
Calls
$651K
Puts
$145K
Net Calls
+$506K
Net Calls Change
+$285K
Top Buyers
| 1 |
CC
Clearline Capital
New York
|
+$148K |
| 2 |
BlackRock
New York
|
+$86.5K |
| 3 |
TC
Tejara Capital
London,
United Kingdom
|
+$57.3K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$12.4K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.16K |
Top Sellers
| 1 |
SSP
Sixth Street Partners
Dallas,
Texas
|
-$467K |
| 2 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$59.6K |
| 3 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$35.3K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$32.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$12.9K |
